At the Congenital Heart Center at C.S. Mott Children's Hospital, our goal is to provide the best possible care for infants, children and adolescents with all forms of congenital and acquired heart disease, as well as adults with congenital heart disease.
Heart failure in children is often caused by a congenital heart defect the child is born with, heart failure due to genetic defects, heart muscle abnormalities (cardiomyopathy), infection, arrhythmia, hypertension, valve disease or other medical conditions. C.S. Mott Children’s Hospital is one of the nation’s top children’s heart programs, and the Michigan Medicine Transplant Center is the largest and most experienced transplant center in Michigan.
A heart transplant improves the length and quality of life of children whose own hearts have failed. At the University of Michigan Pediatric Heart Transplant Program, our dedicated, multidisciplinary team of pediatric cardiac transplant surgeons and transplant cardiologists provides coordinated and comprehensive evaluation, treatment and follow-up for children from newborn to 18 years old and our active research program means our patients have access to the newest treatments available.
Pulmonary atresia (PA) is a rare congenital abnormality of heart development where the pulmonary valve that controls blood flow from the right side of the heart to the lungs doesn’t form (atresia).
C.S. Mott Children’s Hospital transplant nurses, transplant coordinators, social workers and all our team members are committed to helping your family understand as much as possible about the transplant process. We are here for you and happy to answer any questions along the way.
A ventricular assist device (VAD) is a mechanical pump that is placed into a poorly functioning heart to improve the circulation of blood through the body. A VAD is put in to help organs get better and to improve heart failure symptoms. The Congenital Heart Center at C.S. Mott Children’s Hospital is a destination for children and families with complex heart disease, with special expertise in the use of VADs for children with heart failure.
